Cornelio Santibanez

The University of Texas MD Anderson Cancer Center

Affiliations

Institute for Cell Therapy Discovery & Innovation

NoneCornelio Santibanez is currently serving as a Institute For Cell Therapy Discovery & Innovation faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Cornelio Santibanez

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

cell biology immunology cancer immunotherapy immune responses immunotherapy cellular therapy cancer cells leukemia cell death cell therapy hematological malignancies immune checkpoint inhibitors abstract 5199 acute myeloid leukemia

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 5199: Upar-Targeting Car-Nk Cells Enhance Cytotoxicity Against Acute Myeloid Leukemia. Cancer Research (2026)

cell therapycancer immunotherapycell deathimmunologycell biologyhematological malignanciesimmunotherapycellular therapyimmune responsesacute myeloid leukemiaabstract 5199cancer cellsleukemiaimmune checkpoint inhibitors

1
10 / page

Cornelio Santibanez

The University of Texas MD Anderson Cancer Center

Affiliations

Institute for Cell Therapy Discovery & Innovation

NoneCornelio Santibanez is currently serving as a Institute For Cell Therapy Discovery & Innovation faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Cornelio Santibanez

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 5199: Upar-Targeting Car-Nk Cells Enhance Cytotoxicity Against Acute Myeloid Leukemia. Cancer Research (2026)

1
10 / page